STOCK TITAN

Bausch Health Companies Inc - BHC STOCK NEWS

Welcome to our dedicated news page for Bausch Health Companies (Ticker: BHC), a resource for investors and traders seeking the latest updates and insights on Bausch Health Companies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bausch Health Companies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bausch Health Companies's position in the market.

Rhea-AI Summary
Bausch Health and Ortho Dermatologics announce FDA approval for CABTREO, the first and only triple-combination topical treatment for acne
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
fda approval
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.14%
Tags
none
-
Rhea-AI Summary
Bausch Health Companies Inc. to release Q3 financial results on Nov. 2, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
earnings
Rhea-AI Summary
Salix Pharmaceuticals releases Liver Health Trends Report, highlighting a 9% increase in chronic liver disease (CLD) and cirrhosis mortality. Staffing shortages and disparities in CLD care are also identified.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.7%
Tags
none
-
Rhea-AI Summary
Bausch Health Companies Inc. and Salix Pharmaceuticals partner with Bellamy Young to educate people impacted by hepatic encephalopathy (HE) caused by cirrhosis. Bellamy shares her personal experience to help patients, families, and caregivers understand the disease and overcome stigma. UnderstandingHE.com provides educational tools and resources.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
partnership
-
Rhea-AI Summary
Bausch + Lomb completes acquisition of XIIDRA for $2.5 billion, funded by $1.4 billion senior secured notes and $500 million term B loans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
acquisition
Rhea-AI Summary
Bausch + Lomb completes acquisition of XIIDRA for $2.5 billion, funded by $1.4 billion senior secured notes and $500 million term B loans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
acquisition
-
Rhea-AI Summary
Bausch Health Companies and OraPharma partner with LULAC to educate Hispanic community about gum disease. Gum disease affects 65 million American adults and is more common among Latinos. Partnership includes awareness campaign with patient ambassador Alex Rodriguez. OraPharma to provide educational resources and attend National Health Summit. Treatment option for gum disease is antibiotic ARESTIN®.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
none
-
Rhea-AI Summary
Bausch Health CFO resigns, interim replacement identified
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.77%
Tags
none
Rhea-AI Summary
Bausch Health announces availability of new treatment for ulcerative colitis in Canada
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
none
Bausch Health Companies Inc

NYSE:BHC

BHC Rankings

BHC Stock Data

3.83B
305.94M
8.18%
81.01%
6.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
CA
Laval

About BHC

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###